CTLA-4 ICB & A2BR antagonism  ➣ anti-CTLA-4mAb:
UC10-4F10 (359)
➣ A2BR antagonist:
PSB1115 (359)  ➣ Breast: 4T1.2 (359)
➣ Melanoma: B16-F10 (359)  ➣ Metastasis formation ↓ (359)
➣ Survival ↑ (359)